Development of Clinician-Reported Outcome and Patient-Reported Outcome Measures for Eyebrow, Eyelash, and Nail Assessment in Alopecia Areata

August 2020 in “ American Journal of Clinical Dermatology ”

Kathleen W. Wyrwich, Helen Kitchen, S.L. Knight, Natalie V. J. Aldhouse, Jake Macey, Fabio P. Nunes, Yves Dutronc, Natasha Atanaskova Mesinkovska, Justin Ko, Brett King

Alopecia Areata eyebrow assessment eyelash assessment nail assessment Clinician-Reported Outcome Patient-Reported Outcome AA ClinRO PRO

TLDR New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

The development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) measures for assessing eyebrow, eyelash, and nail appearance in patients with Alopecia Areata (AA) provided valuable tools for evaluating outcomes that were significant to patients. These measures, along with photoguides and a PRO measure for eye irritation, offered clear and meaningful assessments, enhancing the understanding of patient experiences and treatment impacts in AA.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research The Alopecia Areata Investigator Global Assessment Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials

86 citations , January 2020 in “British Journal of Dermatology”

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

research Nail Changes in Alopecia Areata: An Update and Review

45 citations , January 2018 in “International Journal of Dermatology”

Nail problems are common in people with alopecia areata, often leading to cosmetic and functional issues, but more research is needed for treatment guidelines.

research Development of Uniform Protocol for Alopecia Areata Clinical Trials

2 citations , November 2015 in “Journal of Investigative Dermatology Symposium Proceedings”

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

research Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss

17 citations , December 2013 in “Journal of Investigative Dermatology Symposium Proceedings”

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

research Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases

109 citations , May 2011 in “Dermatologic Therapy”

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Related Community Posts Join

6 / 1000+ results

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 1 year ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Diffuse thinning is so brutal.

in Styling 73 upvotes 2 years ago

A 25-year-old with AGA experienced hair thinning and dandruff, stabilized with topical finasteride and minoxidil but saw minimal regrowth. They seek advice on styling and consider oral minoxidil and microneedling for denser hair.

community Rare Non responder to Finasteride, Dutasteride, and oral minoxidil

in Minoxidil 78 upvotes 1 year ago

A user did not respond to finasteride, dutasteride, and oral minoxidil for hair loss after four years of treatment and is considering scalp micropigmentation (SMP). Other users suggest the hair loss pattern may indicate alopecia areata and recommend seeing a dermatologist.

community Any experience with Latanoprost?

in Product 6 upvotes 4 years ago

Hair loss discussion includes Latanoprost as potential treatment. Mild improvement observed with its use.

community Hair loss after COVID or vaccination isn’t “made up” but it’s also not what TikTok makes it sound like

in Research/Science 2 upvotes 1 month ago

COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.

community DHEA, the culprit behind DUPA ? Read this!

in Research/Science 19 upvotes 2 years ago

High DHEA levels may contribute to hair loss by increasing DHT in hair follicles, potentially explaining why finasteride is ineffective for some. Treatments like high-dose dutasteride and RU58841 are suggested, but the underlying cause, such as adrenal issues, should be investigated.

Related Research

2 / 2 results

research Eyebrow and Eyelash Alopecia: A Clinical Review

6 citations , October 2022 in “American journal of clinical dermatology”

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

research A Technique for Reconstruction of Eyebrows and Eyelashes

15 citations , May 2005 in “Seminars in Plastic Surgery”

The document concludes that hair follicular unit transplantation is an effective method for eyebrow and eyelash reconstruction, with patients happy despite needing regular trimming.